Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 708,719 shares of HALO, which is worth approximately $49.6 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 16,569 shares (Common Stock) at a price of $69.98 per share, resulting in proceeds of $1,159,498. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 709K
3.41% 3M change
6.3% 12M change
Total Value Held $49.6 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2025
SELL
Open market or private sale
$1,159,498 $69.98 p/Share
16,569 Reduced 2.28%
708,719 Common Stock
Dec 01 2025
BUY
Exercise of conversion of derivative security
$134,374 $8.11 p/Share
16,569 Added 2.23%
725,288 Common Stock
Nov 26 2025
SELL
Bona fide gift
-
25,000 Reduced 3.41%
708,719 Common Stock
Nov 12 2025
SELL
Open market or private sale
$1,419,800 $70.99 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Nov 12 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Nov 11 2025
SELL
Open market or private sale
$1,376,200 $68.81 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Nov 11 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Nov 10 2025
SELL
Open market or private sale
$1,380,200 $69.01 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Nov 10 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Oct 03 2025
SELL
Open market or private sale
$1,402,800 $70.14 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Oct 03 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Oct 02 2025
SELL
Open market or private sale
$1,447,000 $72.35 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Oct 02 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Oct 01 2025
SELL
Open market or private sale
$1,508,000 $75.4 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Oct 01 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Sep 04 2025
SELL
Open market or private sale
$1,487,200 $74.36 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Sep 04 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Sep 03 2025
SELL
Open market or private sale
$1,488,400 $74.42 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Sep 03 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Sep 02 2025
SELL
Open market or private sale
$1,468,800 $73.44 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Sep 02 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Aug 13 2025
SELL
Open market or private sale
$1,289,800 $64.49 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Aug 13 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock
Aug 12 2025
SELL
Open market or private sale
$1,272,400 $63.62 p/Share
20,000 Reduced 2.65%
733,719 Common Stock
Aug 12 2025
BUY
Exercise of conversion of derivative security
$162,200 $8.11 p/Share
20,000 Added 2.58%
753,719 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
Director
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO